Sorrento Therapeutics Inc

NASDAQ:SRNE   3:59:59 PM EDT
1.59
+0.08 (+5.30%)
Debt Financing / Related, Mergers / Acquisitions

Scilex Holding A Majority-Owned Subsidiary Of Sorrento Therapeutics Enters Into A Non-Binding Term Sheet

Published: 03/25/2022 13:26 GMT
Sorrento Therapeutics Inc (SRNE) - Scilex Holding Company, a Majority-owned Subsidiary of Sorrento Therapeutics, Inc., Enters Into a Non-binding Term Sheet for a $5 Billion Committed Equity Financing Facility to Be Effective in Connection With the Closing of the Merger With Vickers Vantage Corp I.
Scilex Holding Company, a Majority-owned Subsidiary of Sorrento Therapeutics, Inc., Enters Into a Non-binding Term Sheet.
Scilex Holding Company - Would Not Be Obligated to Utilize Any of $5 Billion Facility and Would Be Able to Enter Other Financing Transactions.
Scilex Holding Company - No Warrants Will Be Issued in Connection With Facility.
Scilex Holding - Enters Into Non-binding Term Sheet for a $5 Billion Committed Equity Financing Facility to Be Effective in Connection With Deal Closing.